CMP
CMP
CMP - Cipla Medpro - Operational Update
CIPLA MEDPRO SOUTH AFRICA LIMITED
(formerly Enaleni Pharmaceuticals Limited)
(Incorporated in the Republic of South Africa)
(Registration number 2002/018027/06)
(ISIN Number: ZAE000128179 Share Code: CMP)
("Cipla Medpro" or "the Group")
OPERATIONAL UPDATE
Shareholders are advised that at the annual results presentation of Cipla Medpro
held on 31 March 2009, it was mentioned that revenue for the first quarter of
2009 for Cipla Medpro Holdings (Pty) Ltd, excluding the Agrimed business and
manufacturing operations, was R239,7 million, which is approximately 29% higher
than that of the prior comparative period. Revenues from the manufacturing
operations and Agrimed are currently not material to the Group.
In addition, it was mentioned that payment of a dividend would be recommended to
the board of Cipla Medpro, payable to shareholders in 2010 for the financial
year ended 31 December 2009.
Johannesburg
1 April 2009
Investment bank and sponsor
Nedbank Capital
Date: 01/04/2009 10:47:01 Produced by the JSE SENS Department.
The SENS service is an information dissemination service administered by the
JSE Limited (`JSE`). The JSE does not, whether expressly, tacitly or
implicitly, represent, warrant or in any way guarantee the truth, accuracy or
completeness of the information published on SENS. The JSE, their officers,
employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature,
howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
